Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Deficiency of Splicing Factor 1 (SF1) Reduces Intestinal Polyp Incidence in ApcMin/+ Mice

View through CrossRef
Background: Splicing factor 1 (SF1) is a conserved alternative splicing factor expressed in many different mammalian cell types. The genetically modified Sf1+/− (or Sf1β-geo/+) mice express reduced levels of SF1 protein in mouse tissues, including in cells of the intestines. Mutational inactivation of human adenomatous polyposis coli (APC) gene deregulates the Wnt signaling pathway and is a frequent genetic event in colon cancers. Mice with a point mutation in the Apc gene (ApcMin/+) also develop numerous intestinal polyps at a young age. Our aim was to determine the effect of reduced SF1 levels on polyp development due to the strong driver ApcMin/+ mutation. Methods: We utilized mice genetically deficient for expression of SF1 to assess how SF1 levels affect intestinal tumorigenesis. We crossed ApcMin/+ to Sf1+/− mice to generate a cohort of heterozygous mutant ApcMin/+;Sf1+/− mice and compared intestinal polyp development in these mice to that in a control cohort of sibling ApcMin/+ mice. We compared total polyp numbers, sizes of polyps and gender differences in polyp numbers between ApcMin/+;Sf1+/− and ApcMin/+ mice. Results: Our results showed that ApcMin/+ mice with lower SF1 expression developed 25–30% fewer intestinal polyps compared to their ApcMin/+ siblings with normal SF1 levels. Interestingly, this difference was most significant for females (ApcMin/+;Sf1+/− and ApcMin/+ females developed 39 and 55 median number of polyps, respectively). Furthermore, the difference in polyp numbers between ApcMin/+;Sf1+/− and ApcMin/+ mice was significant for smaller polyps with a size of 2 mm or less, whereas both groups developed similar numbers of larger polyps. Conclusions: Our results suggest that lower SF1 levels likely inhibit the rate of initiation of polyp development due to ApcMin/+ driver mutation in the mouse intestine. Thus, therapeutic lowering of SF1 levels in the intestine could attenuate intestinal polyp development.
Title: Deficiency of Splicing Factor 1 (SF1) Reduces Intestinal Polyp Incidence in ApcMin/+ Mice
Description:
Background: Splicing factor 1 (SF1) is a conserved alternative splicing factor expressed in many different mammalian cell types.
The genetically modified Sf1+/− (or Sf1β-geo/+) mice express reduced levels of SF1 protein in mouse tissues, including in cells of the intestines.
Mutational inactivation of human adenomatous polyposis coli (APC) gene deregulates the Wnt signaling pathway and is a frequent genetic event in colon cancers.
Mice with a point mutation in the Apc gene (ApcMin/+) also develop numerous intestinal polyps at a young age.
Our aim was to determine the effect of reduced SF1 levels on polyp development due to the strong driver ApcMin/+ mutation.
Methods: We utilized mice genetically deficient for expression of SF1 to assess how SF1 levels affect intestinal tumorigenesis.
We crossed ApcMin/+ to Sf1+/− mice to generate a cohort of heterozygous mutant ApcMin/+;Sf1+/− mice and compared intestinal polyp development in these mice to that in a control cohort of sibling ApcMin/+ mice.
We compared total polyp numbers, sizes of polyps and gender differences in polyp numbers between ApcMin/+;Sf1+/− and ApcMin/+ mice.
Results: Our results showed that ApcMin/+ mice with lower SF1 expression developed 25–30% fewer intestinal polyps compared to their ApcMin/+ siblings with normal SF1 levels.
Interestingly, this difference was most significant for females (ApcMin/+;Sf1+/− and ApcMin/+ females developed 39 and 55 median number of polyps, respectively).
Furthermore, the difference in polyp numbers between ApcMin/+;Sf1+/− and ApcMin/+ mice was significant for smaller polyps with a size of 2 mm or less, whereas both groups developed similar numbers of larger polyps.
Conclusions: Our results suggest that lower SF1 levels likely inhibit the rate of initiation of polyp development due to ApcMin/+ driver mutation in the mouse intestine.
Thus, therapeutic lowering of SF1 levels in the intestine could attenuate intestinal polyp development.

Related Results

Abstract 4244: Black soybean seed coat extract suppress intestinal tumorigenesis in APCmin mice
Abstract 4244: Black soybean seed coat extract suppress intestinal tumorigenesis in APCmin mice
Abstract Background: Colorectal cancer (CRC) is a major cause of cancer-related deaths in Japan and worldwide. Since CRC has been reported to have close relationship...
The nuclear receptors SF1 and COUP-TFII cooperate on the Insl3 promoter in Leydig cells
The nuclear receptors SF1 and COUP-TFII cooperate on the Insl3 promoter in Leydig cells
  In brief The insulin-like 3 (INSL3) hormone produced by Leydig cells is essential for proper male sex differentiation, ...
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
<p><em><span class="markedContent"><span style="left: calc(var(--scale-factor)*195.53px); top: calc(var(--scale-factor)*496.87px); font-size: calc(var(--scale-...
Genome-wide survey of allele-specific splicing in humans
Genome-wide survey of allele-specific splicing in humans
Abstract Background Accurate mRNA splicing depends on multiple regulatory signals encoded in the transcribed RNA sequence. Many examples of mutat...
PTH-041 Polyp Cancers: When is Surgical Resection Needed ?
PTH-041 Polyp Cancers: When is Surgical Resection Needed ?
Introduction The Bowel Cancer Screening Program (BCSP) has been successful in detecting early stage bowel cancer, including polyp cancers. Most polyp cancers ar...
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract Alternative mRNA splicing is dysregulated in many cancers including lung adenocarcinoma. These aberrant splicing events can sometimes be explained by mutati...
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
Objective: To demonstrate vitamin D deficiency in the general population of Punjab Study Design: Observational, Cross-Sectional Place and Duration: Multicentre study co...

Back to Top